Journey Medical Corp. (DERM)
3.395
-0.16
(-4.37%)
USD |
NASDAQ |
Nov 20, 10:35
Journey Medical Free Cash Flow : -8.621M for Sept. 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2026 | -8.621M |
| June 30, 2026 | -7.567M |
| March 31, 2026 | -6.775M |
| December 31, 2025 | -12.52M |
| September 30, 2025 | -18.93M |
| June 30, 2025 | -17.71M |
| March 31, 2025 | -21.94M |
| December 31, 2024 | -24.13M |
| September 30, 2024 | -27.78M |
| Date | Value |
|---|---|
| June 30, 2024 | -7.877M |
| March 31, 2024 | 1.177M |
| December 31, 2023 | 0.24M |
| September 30, 2023 | 12.83M |
| June 30, 2023 | -13.20M |
| March 31, 2023 | -20.37M |
| December 31, 2022 | -33.53M |
| September 30, 2022 | -34.10M |
| June 30, 2022 | -28.52M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Talphera, Inc. | -12.79M |
| Fortress Biotech, Inc. | 120.19M |
| Relmada Therapeutics, Inc. | -51.86M |
| Turn Therapeutics, Inc. | -5.347M |
| ANI Pharmaceuticals, Inc. | 199.91M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -3.437M |
| Cash from Financing (Quarterly) | 0.117M |
| Free Cash Flow Per Share (Quarterly) | -0.1224 |
| Free Cash Flow to Equity (Quarterly) | -3.517M |
| Free Cash Flow to Firm (Quarterly) | -2.518M |
| Free Cash Flow Yield | -9.00% |